Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$437K Sell
11,593
-3
-0% -$119 0.08% 265
2026
Q2
$441K Buy
11,596
+149
+1% +$5.3K 0.08% 289
2026
Q1
$343K Buy
11,447
+2,341
+26% +$74.3K 0.07% 339
2025
Q4
$266K Buy
+9,106
New +$241K 0.06% 393

Other funds holding IX

Abel Hall LLC's IX Position: Q3 2026 in Review

Abel Hall LLC reduced its ORIX (IX) stake by 0.03% in Q3 2026, selling an estimated $119 and leaving 11,593 shares worth $437K. The position accounts for 0.08% of the portfolio, ranked #265.

Abel Hall LLC first reported a position in IX in Q4 2025 and has held it in 4 quarters since. The position peaked at $441K in Q2 2026. 55 funds tracked by Wall St. Rank hold IX as of Q3 2026.

  • Abel Hall LLC held 11,593 shares of ORIX worth $437K as of Q3 2026.
  • Abel Hall LLC sold 3 ORIX shares in Q3 2026, an estimated $119.
  • ORIX made up 0.08% of Abel Hall LLC's portfolio in Q3 2026, its #265 holding.
  • Abel Hall LLC first reported a position in ORIX in Q4 2025 and has held it in 4 quarters since.
  • Abel Hall LLC's ORIX position peaked at $441K in Q2 2026.
  • 55 funds tracked by Wall St. Rank held ORIX as of Q3 2026.

Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.